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Background/aim: Bordetella pertussis infection remains an important health problem in adults due to the increasing prevalence in recent
years. Pertussis in adults can be easily overlooked or misdiagnosed. We aimed to determine the prevalence of pertussis in adult patients
with acute cough and the clinical features of the pertussis cases.
Materials and methods: Internal Medicine and Pulmonology inpatient wards and outpatient clinics were screened between March 2017
and June 2018. Patients with cough duration between 1 week and 1 month were enrolled. Those who were on antibiotics for more than
5 days were excluded. A total of 115 patients were enrolled. Nasopharyngeal swabs were taken and real-time polymerase chain reaction
analyses were done.
Results: According to the pertussis case definition, 47.8% of the patients were diagnosed with probable pertussis. We found the prevalence
of pertussis as 3.5% in our cohort. All of the patients with pertussis had a history of paroxysmal cough with a mean duration of 20 days.
Conclusions: These results show that pertussis continues to be a health problem for adults and may present with acute cough. The
growing number of adult pertussis cases suggest that vaccination of children is inadequate to prevent pertussis and the concept of ‘lifelong
vaccination’ should be strengthened.
Key words: Bordetella pertussis, polymerase chain reaction, surveillance

1. Introduction
Whooping cough, which we know for more than a century,
is a highly contagious and life-threatening respiratory
system disease and has an impact especially on newborns,
pregnant women, and elderly. The connection between
pertussis and the causative bacteria was established in 1900
and the whole-cell pertussis vaccine was first introduced in
the 1930s [1]. Since then, there have been great advances
in controlling the disease spread, however, pertussis
continues to be a problem for vulnerable individuals.
Although the incidence of pertussis decreased
dramatically with childhood vaccination programmes, in
recent years there has been an increase in the incidence

worldwide. It is thought that waning immunity, shift
from a whole-cell vaccine to an acellular vaccine, active
surveillance, better diagnostic tests and increased
awareness might be the possible causes of this increase
[2–4]. According to the data of the Centers for Disease
Control and Prevention (CDC) in Washington, the highest
number of case reports were announced in 2012, 70 years
after 1942 [3]. The number of cases reported in England in
the last decade has also increased1. The number of reported
pertussis cases over the past two decades for England1,
The European Union and European Economic Area (EU/
EEA) countries2, Turkey3 and United States4 are shown
respectively in Figure 1a, 1b, 1c and 1d. In the past, infants
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Figure 1. Number of reported pertussis cases over the past 2 decades, a: England; data derived from laboratory confirmed cases of
pertussis in England from 1994 to 2017. Pertussis annual report, b: The European Union and European Economic Area (EU/EEA)
countries; data derived from European Centre for Disease Prevention and Control (ECDC), Surveillance ATLAS of Infectious Diseases,
surveillance and disease data, c: Turkey; data derived from WHO vaccine-preventable diseases: monitoring system. 2020 global summary
incidence time series for Turkey, d: USA; data derived from CDC Surveillance and Reporting; pertussis cases by year.

used to constitute the majority of cases. However, in recent
years there is a significant increase in the prevalence of
pertussis among adolescents and adults in many countries.
Age distribution of reported pertussis cases in EU/EEA
countries2 is shown in Figure 2.
Polymerase chain reaction (PCR) is the most sensitive
method for rapid detection of Bordetella pertussis.
However, as is the case with the gold standard method,
culture, its sensitivity decreases over time as the duration
of cough increases. PCR is a helpful diagnostic test until the
4th week of cough. However, the use of PCR for diagnosis
is not recommended after the fifth day of the antibiotic
use, as antibiotic use may cause false-negative results [5].
After the inclusion of PCR test results to pertussis case
definition, PCR use became more widespread, and in
2012 more than 84% of cases in the United States were
diagnosed with PCR [6].
It is recommended that milder cases with few
symptoms and short-term cough should be included in
studies identifying B. pertussis infections, since the disease
may demonstrate an atypical course in some individuals.

Active surveillance studies suggest that pertussis frequency
is much higher than that is reported. Many pertussis
cases remain undiagnosed and cannot be reported due
to atypical disease course and limitations in laboratory
tests [7, 8]. This might well be the case in Turkey. Studies
conducted in variable patient groups in different cities of
Turkey showed that the prevalence of pertussis-positive
cases can be as high as 26% [9,10].
The primary aim of this study was to determine the
prevalence of pertussis in adult patients with acute cough.
The second aim was to determine the clinical features,
course, and outcome of the identified pertussis cases.
2. Materials and methods
The patients who were admitted to Internal Medicine
inpatient wards of a University Hospital and those seen at
the Internal Medicine and Pulmonology outpatient clinics
of the same hospital between March 2017 and June 2018
were screened. Patients older than 18 years of age and
with cough duration between 1 week and 1 month were
enrolled in the study. Patients who were on antibiotics for
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Figure 2. Age distribution of reported pertussis cases over the past 2 decades, The European Union and
European Economic Area (EU/EEA) countries; data derived from European Centre for Disease Prevention and
Control (ECDC), Surveillance ATLAS of Infectious Diseases, surveillance and disease data.

more than 5 days, patients with cough duration less than
1 week and more than 1 month, and patients who did not
consent were excluded. Nasopharyngeal swabs were taken
from the patients who were eligible and who consented.
The most widely used case definition as accepted by
the Council of State and Territorial Epidemiologists and
used to report to the Centers for Disease Control and
Prevention, which is also the reference in this study, is
summarized in Table 15.
Sterile single pack, thin tip, flexible, plastic swabs
(FloqSwabsTM Flocked swab 503CS01, Copan
Diagnostics Inc., USA) were used to collect nasopharyngeal
specimens from patients. DNA extraction was performed
with BD MAXTM ExKTM DNA-1 extraction kit from
nasopharyngeal swab samples.
Multi-targeted BioGX Sample-ReadyTM open system
reaction kits were used when performing Real TimePolymerase Chain Reaction (RT-PCR), which can detect
Bordetella pertussis (IS481), Bordetella parapertussis
(pIS1001), Bordetella holmesii (hIS1001), pertussis
toxin gene (ptxS1), the sample extraction control and a
Drosophila (sample processing control, SPC) DNA as an
internal amplification control. RT-PCR was performed
with the automated system of the BD MaxTM System
(Becton Dickinson, USA) and results were evaluated as
recommended by the producer.

3. Results
There were 115 patients who met inclusion criteria and
were enrolled in the study. The mean age of the patients
was 46.4 years and 72 (62.6%) of the patients were
female (Table 2). More than half of the patients had at
least one chronic condition, the most prevalent one
being hypertension. Most of the patients were recruited
from the outpatient clinics. The duration of cough was
lower than 21 days in 83 (72.2 %) of the patients (Table
2). According to CDC pertussis case definitions, 47.8%
of the patients were diagnosed with probable pertussis.
Paroxysms of cough were present in 73% of the enrolled
patients.
Four patients were diagnosed to have pertussis with
regards to B. pertussis PCR results, hence the prevalence
of pertussis in this adult patient population with acute
cough was 3.5%. All of the patients described paroxysms
of cough and one patient described posttussive vomiting
(Table 3). The fourth patient with pertussis, who was a
66-year-old woman with gastric cancer, was hospitalized
for gastrointestinal bleeding and died on the 30th day of
her admission.
4. Discussion
Pertussis is a disease that may affect all age groups,
although it is perceived as a childhood disease. Adults can

Council of State and Territorial Epidemiologists Position Statement (2013). Revision of the pertussis surveillance case definition to more accurately
capture the burden of disease among infants <1 year of age. [online]. Website https://cdn.ymaws.com/www.cste.org/resource/resmgr/PS/13-ID-15.pdf
[Accessed: 05 January 2022].
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Table 1. Pertussis case classification.
Confirmed
cases

Probable cases

Definition

1

Acute cough illness (any duration)

+

Criteria
Criteria group

Clinical criteria

2

3

1

Cough ≥2 weeks duration

+

+

+

Inspiratory whoop

o

o

o

o

o

o

Paroxysms of coughing

o

o

o

o

o

o

Posttussive vomiting

o

o

o

o

o

o

o

o

o

o

o

o

Apnoea (with or without cyanosis), (For infants <1 year of age only)
Laboratory
criteria

Isolation of B. pertussis from a clinical specimen

2*

3*

+

+

4
+

+

Positive PCR for B. pertussis

+

Epidemiological Contact with a laboratory-confirmed case (classified as “confirmed”)
linkage
Contact with a laboratory-confirmed infant case (classified as “probable”)

+
+

o
o

+

*For infants <1 year of age only
Notes: + = All “+” criteria in the same column are necessary to classify a case. o = At least one of these “o” (Optional) criteria in each
category (e.g., clinical criteria and laboratory criteria) in the same column—in conjunction with all “+” criteria in the same column—is
required to classify a case.
Data derived from Council of State and Territorial Epidemiologists Position Statement1
Council of State and Territorial Epidemiologists Position Statement (2013). Revision of the pertussis surveillance case definition to more accurately
capture the burden of disease among infants <1 year of age. [online]. Website https://cdn.ymaws.com/www.cste.org/resource/resmgr/PS/13-ID-15.pdf
[Accessed: 05 January 2022].
1

be affected by atypical and mild forms of the disease, and
they also act as an important source of infection for infants.
Although, pertussis is well-known as an aetiological factor
in adults with prolonged cough, we aimed to determine its
prevalence in adult patients who present with acute cough
and found a prevalence of 3.5%. Previous data have shown
that the actual prevalence of pertussis might be quite
high (Figure 1). Therefore, surveillance studies become
more important in terms of demonstrating the burden
of disease, determining the epidemiological trends and
using resources more effectively. In this respect, our study
showed that pertussis is one of the diseases that should not
be neglected in the adult age group.
The prevalence of pertussis in different studies can be
quite variable due to the selection criteria of the patients
and the differences in the laboratory methods. The mean
prevalence of pertussis was found to be 3% (0% to 6.2%)
in adults with cough duration between 2 to 4 weeks in a
European multicentre study [11]. In a study evaluating 214
adolescent and adult patients with cough duration of more
than 2 weeks, pertussis PCR was found to be positive in
15 (7%) subjects [12]. Another study evaluating pertussis

seroprevalence in adults, 52 (9.7%) of 538 patients with
cough duration for more than 2 weeks suggested that their
B. pertussis antibody levels were compatible with acute or
recent infection [13].
Many health authorities believe that reported cases do
not reflect actual numbers6 [14]. It has been postulated that
reported pertussis cases are 40 to 160 times less than the
actual disease incidence, and asymptomatic infections are
4 to 22 times more common than symptomatic infections
[15]. The reported prevalence of pertussis was variable
among studies in different age groups with different
clinical presentations in our country, higher than 20% in
many of them [9,10]. As Shown in Figure 1 and Figure
2, not only has there been an increase in the number of
reported cases over the last 2 decades, but also there has
been a change in the age distribution of the reported cases.
In the early 2000s, only 5%–10% of pertussis cases reported
in the United Kingdom were older than 24 years of age, but
in recent years this rate is over 50%7. A similar change is
also seen in Denmark, where the proportion of the over
20-year-olds in the distribution of laboratory-verified
cases increased from 14% to 43% from 1995 to 2013 [16].

World Health Organization (2001). World Health Organization Department of Vaccines and Biologicals, Pertussis Surveillance: A Global Meeting
Geneva. [online]. Website https://apps.who.int/iris/bitstream/handle/10665/66828/WHO-VB-01.19-eng.pdf?sequence=1&isAllowed=y [Accessed: 07
July 2019].
6

Public Health England (2018). Laboratory confirmed cases of pertussis in England from 1994 to 2017. Pertussis annual report: supplementary data
tables 2017. [online]. Website https://www.gov.uk/government/publications/whooping-cough-pertussis-statistics [Accessed: 14 March 2020].
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Table 2. Demographic characteristics and clinical features of patients with acute cough disease (n = 115).
Characteristics

n (%)

Age

46.4 (18.6) *

Female gender

72 (62.6)

Medical history

No chronic illness

49 (42.6)

Hypertension

31 (27.0)

Diabetes mellitus

17 (14.8)

Chronic lung disease

28 (24.3)

Coronary artery disease

11 (9.6)

Malignancy

11 (9.6)

Other chronic conditions**

24 (20.9)

Smoking

34 (29.6)

Type of admission

Duration of cough

Characteristics of cough

Outpatient

99 (86.1)

Inpatient

16 (13.9)

7–14 day

38 (33.0)

14–21 day

45 (39.1)

21–28 day

32 (27.8)

History of contact with a coughing person before illness

21 (18.3)

Paroxysm

84 (73.0)

Vomiting after coughing

10 (8.7)

Dyspnoea

62 (53.9)

Chest pain

39 (33.9)

Fever

28 (24.3)

Headache

47 (40.9)

Disturbance of sleep

55 (47.8)

Disturbance of daily activities

40 (34.8)

Notes: Values are given in numbers and percent n (%) if otherwise specified, one patient might have more than
one chronic condition.
* mean (standard deviation)
**chronic kidney disease, chronic liver disease, heart failure, heart valve disorders, rheumatological diseases,
hypothyroidism, cerebrovascular disease, cardiac arrhythmia, Parkinson disease, and thrombophilia
Table 3. Characteristics of patients with a positive Bordetella PCR.
Patient

Age

Sex

Duration of
cough (day)

Paroxysms

Posttussive
vomiting

Disturbance of sleep
and daily activities

Medical history

Inpatient/
outpatient

1*

34

M

18

Yes

No

Yes

No chronic illness

Outpatient

2

69

F

28

Yes

No

Yes

HT

Outpatient

3

34

F

20

Yes

No

Yes

No chronic illness

Outpatient

4**

66

F

15

Yes

Yes

Yes

Gastric cancer

Inpatient

* He was an officer in a high school.
** Hospitalized in the intensive care unit because of gastrointestinal bleeding and died in the hospital.
F: female, M: male, PCR: polymerase chain reaction HT: hypertension
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Studies evaluating transmission pathways of pertussis in
children indicate that adolescents and adults are reservoirs
for pertussis [17]. The sources of pertussis infection were
adults, mainly the parents and in-household contacts, in
70%–80% of paediatric pertussis cases [17]. It is evident
that adults are the major source of infection who transmit
pertussis to babies, who have the highest morbidity and
mortality. Neither having pertussis infection nor having
pertussis vaccine does provide life-long protection.
Immunity gained in both ways decreases with time [15].
Although the three doses of primary pertussis vaccination
coverage among children under 1 year of age have been
96% and over in Turkey, seroepidemiological data
from our country demonstrated that adults constitute a
potential reservoir for pertussis8. It was shown that 90%
of adults that presented to the outpatient clinic did not
have protective antibody levels for pertussis [18]. Thus,
a lifelong vaccination strategy for pertussis should be
established. Many guidelines now recommend to have a
pertussis booster dose in adulthood in a way that one of
the tetanus-diphtheria boosters to be replaced by tetanusdiphtheria-acellular pertussis booster9,10,11.
In our study, almost half of patients presenting with
acute cough were diagnosed as probable pertussis cases
with clinical criteria. Vittucci and colleagues found that
the sensitivity of the clinical definition in diagnosing
pertussis cases was 30.2% in infants [19], thus, it is not
possible to exclude the diagnosis of pertussis by clinical
features. On the other hand, pertussis is a disease that
can easily be overlooked as well [19,20]. We found that
the mean duration of paroxysmal cough within pertussis
positive cases was 20 days. It is known that there may
be delays in the diagnosis because of not considering
pertussis as a priority in differential diagnosis even if the
patients are admitted early [19]. Heil and colleagues found
that the median time from the onset of the disease until

the diagnostic test request was 28 days (21–47 days) [21].
Early detection and proper treatment of pertussis can
reduce the transmission of the infection [21].
One of the limitations of our study was that the
patients were not screened by any laboratory method
other than PCR. Although patients with cough duration
of more than 4 weeks were excluded due to decreasing
sensitivity of PCR, it still might have yielded false-negative
or false-positive results. In addition, we did not make
analyses for other viral and bacterial aetiologies, hence
we could not point out the proportion of pertussis cases
among other microbial aetiologies. On the other hand, the
strengths of the study were its surveillance methodology
and the utilization of PCR. All patients presenting with
cough disease were prospectively screened and those who
fulfilled enrolment criteria were screened by PCR, which is
a fast and highly sensitive diagnostic method.
In conclusion, we demonstrated that in a cohort of
patients presenting with acute cough, half of the patients
were diagnosed as probable pertussis cases with clinical
criteria and the prevalence of pertussis was found to be
3.5%. These results indicate that pertussis can be an
aetiological factor in patients presenting with acute cough
and real-time laboratory tests are needed to verify probable
cases as confirmed cases. Finally, training programmes to
increase pertussis awareness and reinforce the concept of
‘lifelong vaccination’ will help to decrease the burden of
pertussis among adults and its transmission to vulnerable
infants.
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